DEBx Medical receives CE Mark for Debrichem, a novel gel for chronic wound healing
DEBx Medical, the Dutch medical technology company revolutionizing the management of chronic wounds, has successfully completed the CE conformity assessment procedure for Debrichem – a disruptive and innovative topical agent for surgical debridement and an altnerative to the current standard of care.